Literature DB >> 12820373

High level of cFLIP correlates with resistance to death receptor-induced apoptosis in bladder carcinoma cells.

Gun Jönsson1, Staffan Paulie, Alf Grandien.   

Abstract

BACKGROUND: The cellular form of FLICE-inhibitory protein (cFLIP) blocks death receptor-induced apoptosis and has been implicated in tumour progression. cFLIP interacts with caspase-8, thereby preventing activation of the caspase cascade. In this study we investigated the endogenous expression of cFLIP and caspase-8 in bladder carcinoma cells in relation to their sensitivity to death receptor-ligation.
MATERIALS AND METHODS: Apoptosis was induced by agonistic anti-CD95 mAbs or recombinant TRAIL and quantified by the TUNEL technique. The relative mRNA expression of cFLIP and caspase-8 was quantified by real-time PCR. Stable expression of cFLIP long (cFLIPL) was obtained by retroviral transduction.
RESULTS: The relative ratio of cFLIP and caspase-8 was directly correlated to resistance to anti-CD95 or TRAIL-mediated apoptosis. Overexpression of cFLIPL shifted the responsiveness towards resistant status.
CONCLUSION: cFLIP is an important determinant of susceptibility to death receptor-induced apoptosis in bladder carcinomas and could function as a prognostic marker for death receptor sensitivity in future immune therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820373

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

Review 1.  Resistance to TRAIL and how to surmount it.

Authors:  Danijela Maksimovic-Ivanic; Stanislava Stosic-Grujicic; Ferdinando Nicoletti; Sanja Mijatovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 2.  Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas.

Authors:  Christopher Y Thomas; Dan Theodorescu
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

3.  PKCdelta-mediated regulation of FLIP expression in human colon cancer cells.

Authors:  Qingding Wang; Xiaofu Wang; Yuning Zhou; B Mark Evers
Journal:  Int J Cancer       Date:  2006-01-15       Impact factor: 7.396

Review 4.  The promise of TRAIL--potential and risks of a novel anticancer therapy.

Authors:  Ronald Koschny; Henning Walczak; Tom M Ganten
Journal:  J Mol Med (Berl)       Date:  2007-04-17       Impact factor: 4.599

5.  Understanding the Role of the Death Receptor 5/FADD/caspase-8 Death Signaling in Cancer Metastasis.

Authors:  Shi-Yong Sun
Journal:  Mol Cell Pharmacol       Date:  2011-01-01

6.  Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAIL-induced apoptosis.

Authors:  Penny Clarke; Kenneth L Tyler
Journal:  Apoptosis       Date:  2007-01       Impact factor: 4.677

7.  Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells.

Authors:  Imtiyaz Murtaza; Mohammad Saleem; Vaqar Mustafa Adhami; Bilal Bin Hafeez; Hasan Mukhtar
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

8.  Oxidative stress sensitizes bladder cancer cells to TRAIL mediated apoptosis by down-regulating anti-apoptotic proteins.

Authors:  Shai J White-Gilbertson; Laura Kasman; John McKillop; Tejas Tirodkar; Ping Lu; Christina Voelkel-Johnson
Journal:  J Urol       Date:  2009-07-21       Impact factor: 7.450

9.  Expression of FADD and cFLIPL balances mitochondrial integrity and redox signaling to substantiate apoptotic cell death.

Authors:  Kishu Ranjan; Chandramani Pathak
Journal:  Mol Cell Biochem       Date:  2016-09-13       Impact factor: 3.396

10.  Expression and biological significance of c-FLIP in human hepatocellular carcinomas.

Authors:  Xilin Du; Guoqiang Bao; Xianli He; Huadong Zhao; Fang Yu; Qing Qiao; Jianguo Lu; Qingjiu Ma
Journal:  J Exp Clin Cancer Res       Date:  2009-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.